Hanneke W.M. van Laarhoven

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

Joël Shapiro, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof et al. · The Lancet Oncology · 2015 · 2.6K citations

Medicine, Oncology, Surgery +17

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

Annemieke Cats, Edwin P. M. Jansen, Nicole C.T. van Grieken et al. · The Lancet Oncology · 2018 · 576 citations

Medicine, Oncology, Surgery +17

Artificial reporter gene providing MRI contrast based on proton exchange

Assaf A. Gilad, Michael T. McMahon, Piotr Walczak et al. · Nature Biotechnology · 2007 · 402 citations

Medicine, Bioengineering, Molecular Biology +16

The assessment of fatigue: Psychometric qualities and norms for the Checklist individual strength

Margreet Worm-Smeitink, Marieke Gielissen, Lotte Bloot et al. · Journal of Psychosomatic Research · 2017 · 375 citations

Education, Educational Assessment, Psychology +13

Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial

Charles S. Fuchs, Kohei Shitara, Maria Di Bartolomeo et al. · The Lancet Oncology · 2019 · 284 citations · Full text

Medicine, Oncology, Pharmacology +13